Cloned (Comment) | Organism |
---|---|
expressed in Escherichia coli | Leishmania mexicana |
Protein Variants | Comment | Organism |
---|---|---|
additional information | CBT2.8deltaCTE, CBT lacking the characteristic C-terminal extension | Leishmania mexicana |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
4-methyl N-[(S)-1-oxo-1-[(S)-1-oxo-4-phenyl-1-(5-phenylisoxazol-3-yl)butan-2-ylamino]-3-phenylpropan-2-yl]piperazine-1-carboxamide | - |
Leishmania mexicana | |
N-((S)-1-[(S)-1-[1-(benzyloxymethyl)-1H-1,2,3-triazol-4-yl]-1-oxo-3-phenylpropan-2-ylamino]-1-oxo-3-phenylpropan-2-yl)morpholine-4-carboxamide | - |
Leishmania mexicana | |
N-[(2S)-1-[(2S)-1-hydroxy-3-phenyl-1-(5-phenyl-1,2,4-oxadiazol-3-yl)propan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide | - |
Leishmania mexicana | |
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(1-phenyl-1H-1,2,3-triazol-4-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | - |
Leishmania mexicana | |
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(3-phenylisoxazol-5-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | - |
Leishmania mexicana | |
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(5-phenylisoxazol-3-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | - |
Leishmania mexicana | |
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(5-phenyloxazol-2-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | - |
Leishmania mexicana | |
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(5-phenylthiazol-2-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | - |
Leishmania mexicana | |
N-[(S)-1-[(d)-1-(5-benzylisoxazol-3-yl)-1-oxo-4-phenylbutan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide | - |
Leishmania mexicana | |
N-[(S)-1-[(S)-1-(benzo[d]oxazol-2-yl)-1-oxo-3-phenylpropan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide | - |
Leishmania mexicana | |
N-[(S)-1-[(S)-1-(benzo[d]thiazol-2-yl)-1-oxo-3-phenylpropan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide | - |
Leishmania mexicana | |
Nalpha-(morpholin-4-ylcarbonyl)-N-[(1E,3S)-5-phenyl-1-(phenylsulfonyl)pent-1-en-3-yl]-L-phenylalaninamide | - |
Leishmania mexicana | |
Nalpha-(morpholin-4-ylcarbonyl)-N-[(2S)-1-oxo-4-phenyl-1-(5-phenyl-1,2-oxazol-3-yl)butan-2-yl]-L-phenylalaninamide | - |
Leishmania mexicana | |
Nalpha-[(4-methylpiperazin-1-yl)carbonyl]-N-[(1E,3S)-5-phenyl-1-(phenylsulfonyl)pent-1-en-3-yl]-L-phenylalaninamide | - |
Leishmania mexicana |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Leishmania mexicana | - |
- |
- |
Purification (Comment) | Organism |
---|---|
from inclusion bodies | Leishmania mexicana |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
benzyloxycarbonyl-Phe-Arg-p-nitroanilide + H2O | - |
Leishmania mexicana | benzyloxycarbonyl-Phe-Arg + p-nitroaniline | - |
? |
Synonyms | Comment | Organism |
---|---|---|
cystein protease CPB2.8 | - |
Leishmania mexicana |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0000016 | - |
N-[(2S)-1-[(2S)-1-hydroxy-3-phenyl-1-(5-phenyl-1,2,4-oxadiazol-3-yl)propan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide | pH 5.0 30°C | Leishmania mexicana | |
0.000004 | - |
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(5-phenylisoxazol-3-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | one of two purified isomers, pH 5.0 30°C | Leishmania mexicana | |
0.000006 | - |
Nalpha-(morpholin-4-ylcarbonyl)-N-[(2S)-1-oxo-4-phenyl-1-(5-phenyl-1,2-oxazol-3-yl)butan-2-yl]-L-phenylalaninamide | one of two purified isomers, pH 5.0 30°C | Leishmania mexicana | |
0.0000074 | - |
4-methyl N-[(S)-1-oxo-1-[(S)-1-oxo-4-phenyl-1-(5-phenylisoxazol-3-yl)butan-2-ylamino]-3-phenylpropan-2-yl]piperazine-1-carboxamide | pH 5.0 30°C | Leishmania mexicana | |
0.000014 | - |
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(1-phenyl-1H-1,2,3-triazol-4-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | one of two purified isomers, pH 5.0 30°C | Leishmania mexicana | |
0.000015 | - |
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(5-phenyloxazol-2-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | pH 5.0 30°C | Leishmania mexicana | |
0.000048 | - |
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(3-phenylisoxazol-5-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | pH 5.0 30°C | Leishmania mexicana | |
0.000115 | - |
N-[(S)-1-[(S)-1-(benzo[d]oxazol-2-yl)-1-oxo-3-phenylpropan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide | pH 5.0 30°C | Leishmania mexicana | |
0.000118 | - |
N-[(S)-1-[(d)-1-(5-benzylisoxazol-3-yl)-1-oxo-4-phenylbutan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide | pH 5.0 30°C | Leishmania mexicana | |
0.000417 | - |
N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(5-phenylthiazol-2-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | pH 5.0 30°C | Leishmania mexicana | |
0.000767 | - |
N-[(S)-1-[(S)-1-(benzo[d]thiazol-2-yl)-1-oxo-3-phenylpropan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide | pH 5.0 30°C | Leishmania mexicana | |
0.001706 | - |
N-((S)-1-[(S)-1-[1-(benzyloxymethyl)-1H-1,2,3-triazol-4-yl]-1-oxo-3-phenylpropan-2-ylamino]-1-oxo-3-phenylpropan-2-yl)morpholine-4-carboxamide | pH 5.0 30°C | Leishmania mexicana |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000027 | - |
pH 5.0 30°C | Leishmania mexicana | Nalpha-(morpholin-4-ylcarbonyl)-N-[(1E,3S)-5-phenyl-1-(phenylsulfonyl)pent-1-en-3-yl]-L-phenylalaninamide | |
0.00005 | - |
pH 5.0 30°C | Leishmania mexicana | N-[(2S)-1-[(2S)-1-hydroxy-3-phenyl-1-(5-phenyl-1,2,4-oxadiazol-3-yl)propan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide | |
0.000054 | - |
pH 5.0 30°C | Leishmania mexicana | Nalpha-[(4-methylpiperazin-1-yl)carbonyl]-N-[(1E,3S)-5-phenyl-1-(phenylsulfonyl)pent-1-en-3-yl]-L-phenylalaninamide | |
0.00013 | - |
one of two purified isomers, pH 5.0 30°C | Leishmania mexicana | N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(5-phenylisoxazol-3-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | |
0.00019 | - |
one of two purified isomers, pH 5.0 30°C | Leishmania mexicana | Nalpha-(morpholin-4-ylcarbonyl)-N-[(2S)-1-oxo-4-phenyl-1-(5-phenyl-1,2-oxazol-3-yl)butan-2-yl]-L-phenylalaninamide | |
0.00023 | - |
pH 5.0 30°C | Leishmania mexicana | 4-methyl N-[(S)-1-oxo-1-[(S)-1-oxo-4-phenyl-1-(5-phenylisoxazol-3-yl)butan-2-ylamino]-3-phenylpropan-2-yl]piperazine-1-carboxamide | |
0.00044 | - |
one of two purified isomers, pH 5.0 30°C | Leishmania mexicana | N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(1-phenyl-1H-1,2,3-triazol-4-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | |
0.00047 | - |
pH 5.0 30°C | Leishmania mexicana | N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(5-phenyloxazol-2-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | |
0.0015 | - |
pH 5.0 30°C | Leishmania mexicana | N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(3-phenylisoxazol-5-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | |
0.00355 | - |
pH 5.0 30°C | Leishmania mexicana | N-[(S)-1-[(S)-1-(benzo[d]oxazol-2-yl)-1-oxo-3-phenylpropan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide | |
0.00366 | - |
pH 5.0 30°C | Leishmania mexicana | N-[(S)-1-[(d)-1-(5-benzylisoxazol-3-yl)-1-oxo-4-phenylbutan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide | |
0.01294 | - |
pH 5.0 30°C | Leishmania mexicana | N-[(S)-1-oxo-1-[(S)-1-oxo-3-phenyl-1-(5-phenylthiazol-2-yl)propan-2-ylamino]-3-phenylpropan-2-yl]morpholine-4-carboxamide | |
0.02379 | - |
pH 5.0 30°C | Leishmania mexicana | N-[(S)-1-[(S)-1-(benzo[d]thiazol-2-yl)-1-oxo-3-phenylpropan-2-ylamino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide | |
0.0529 | - |
pH 5.0 30°C | Leishmania mexicana | N-((S)-1-[(S)-1-[1-(benzyloxymethyl)-1H-1,2,3-triazol-4-yl]-1-oxo-3-phenylpropan-2-ylamino]-1-oxo-3-phenylpropan-2-yl)morpholine-4-carboxamide |